Bank of Nova Scotia
TDOC icon

Bank of Nova Scotia’s Teladoc Health TDOC Stock Holding History

Bank of Nova Scotia’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,802
Closed -$328K – 1154
2021
Q1 		$328K Sell
1,802
-1,284
-42% -$298K ﹤0.01% 1003
2020
Q4 		$617K Buy
3,086
+394
+15% +$80.1K ﹤0.01% 846
2020
Q3 		$590K Sell
2,692
-195
-7% -$41.3K ﹤0.01% 832
2020
Q2 		$551K Buy
+2,887
New +$506K ﹤0.01% 723

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Nova Scotia's TDOC Position: Q2 2021 in Review

Bank of Nova Scotia sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 1,802 shares — an estimated $328K sold.

Bank of Nova Scotia first reported a position in TDOC in Q2 2020 and held it in 4 quarters. The position peaked at $617K in Q4 2020. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • Bank of Nova Scotia reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • Bank of Nova Scotia sold 1,802 Teladoc Health shares in Q2 2021, an estimated $328K.
  • Bank of Nova Scotia first reported a position in Teladoc Health in Q2 2020 and held it in 4 quarters.
  • Bank of Nova Scotia's Teladoc Health position peaked at $617K in Q4 2020.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Bank of Nova Scotia's 13F filing for Q2 2021, filed 12 Aug 2021.